---
layout: post
title: "康希诺生物-B(06185.HK)获摩根大通增持21.34万股"
date: 2022-04-06 07:37:23 +0800
categories: gelonghui
tags: 格隆汇新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.06185" data-code="06185|116|5" data-code2="06185|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.06185&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 06185_0" data-code="K 06185|116|5" data-code2="K 06185|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>根据联交所最新权益披露资料显示，2022年3月29日，康希诺生物-B(06185.HK)获JPMorgan Chase & Co.以每股均价124.6938港元增持好仓21.34万股，涉资约2661.51万港元。</p>
 <p>增持后，JPMorgan Chase & Co.最新持好仓数目为11,94.096万股，持好仓比例由8.83%上升至9.00%。</p>
 <p align="center"><br/></p><p class="em_media">（文章来源：格隆汇）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204062332682968>

[返回格隆汇新闻](//finews.withounder.com/category/gelonghui.html)｜[返回首页](//finews.withounder.com/)